Academic literature on the topic 'MLPANN'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'MLPANN.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "MLPANN"
Mirbagheri, Sayed Ahmad, Majid Bagheri, Majid Ehteshami, Zahra Bagheri, and Masoud Pourasghar. "MODELING OF MIXED LIQUOR VOLATILE SUSPENDED SOLIDS AND PERFORMANCE EVALUATION FOR A SEQUENCING BATCH REACTOR." Journal of Urban and Environmental Engineering 9, no. 1 (December 27, 2015): 54–65. http://dx.doi.org/10.4090/juee.2015.v9n1.054065.
Full textMirbagheri, Sayed Ahmad, Majid Bagheri, Majid Ehteshami, Zahra Bagheri, and Masoud Pourasghar. "MODELING OF MIXED LIQUOR VOLATILE SUSPENDED SOLIDS AND PERFORMANCE EVALUATION FOR A SEQUENCING BATCH REACTOR." Journal of Urban and Environmental Engineering 9, no. 1 (December 27, 2015): 54–65. http://dx.doi.org/10.4090/juee.2015.v9n1.54-65.
Full textAlizamir, Meysam, Zahra Kazemi, Zohre Kazemi, Majid Kermani, Sungwon Kim, Salim Heddam, Ozgur Kisi, and Il-Moon Chung. "Investigating Landfill Leachate and Groundwater Quality Prediction Using a Robust Integrated Artificial Intelligence Model: Grey Wolf Metaheuristic Optimization Algorithm and Extreme Learning Machine." Water 15, no. 13 (July 4, 2023): 2453. http://dx.doi.org/10.3390/w15132453.
Full textMobasser, Farid, and Keyvan Hashtrudi-Zaad. "A Comparative Approach to Hand Force Estimation using Artificial Neural Networks." Biomedical Engineering and Computational Biology 4 (January 2012): BECB.S9335. http://dx.doi.org/10.4137/becb.s9335.
Full textAlizamir, Meysam, Kaywan Othman Ahmed, Sungwon Kim, Salim Heddam, AliReza Docheshmeh Gorgij, and Sun Woo Chang. "Development of a robust daily soil temperature estimation in semi-arid continental climate using meteorological predictors based on computational intelligent paradigms." PLOS ONE 18, no. 12 (December 27, 2023): e0293751. http://dx.doi.org/10.1371/journal.pone.0293751.
Full textHussain, Bydaa Ali, and Mohammed Sadoon Hathal. "Developing Arabic License Plate Recognition System Using Artificial Neural Network and Canny Edge Detection." Baghdad Science Journal 17, no. 3 (September 1, 2020): 0909. http://dx.doi.org/10.21123/bsj.2020.17.3.0909.
Full textHussain, Bydaa Ali, and Mohammed Sadoon Hathal. "Development of Iraqi License Plate Recognition System based on Canny Edge Detection Method." Journal of Engineering 26, no. 7 (July 1, 2020): 115–26. http://dx.doi.org/10.31026/j.eng.2020.07.08.
Full textPrashanth, M., D. Madhu, K. Ramanarasimh, and R. Suresh. "Effect of Heat Input and Filling Ratio on Raise in Temperature of the Oscillating Heat Pipe with Different Working Fluids Using ANN Model." International Journal of Heat and Technology 40, no. 2 (April 30, 2022): 535–42. http://dx.doi.org/10.18280/ijht.400221.
Full textGebremariam, Gebrekiros Gebreyesus, J. Panda, and S. Indu. "Localization and Detection of Multiple Attacks in Wireless Sensor Networks Using Artificial Neural Network." Wireless Communications and Mobile Computing 2023 (January 10, 2023): 1–29. http://dx.doi.org/10.1155/2023/2744706.
Full textSAHIN, CENK, SEYFETTIN NOYAN OGULATA, KEZBAN ASLAN, HACER BOZDEMIR, and RIZVAN EROL. "A NEURAL NETWORK-BASED CLASSIFICATION MODEL FOR PARTIAL EPILEPSY BY EEG SIGNALS." International Journal of Pattern Recognition and Artificial Intelligence 22, no. 05 (August 2008): 973–85. http://dx.doi.org/10.1142/s0218001408006594.
Full textDissertations / Theses on the topic "MLPANN"
Ó, Vivian Tragante do. "Análise por MLPA das regiões subteloméricas de pacientes com Holoprosencefalia." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/61/61132/tde-09012015-120002/.
Full textIntroduction: Holoprosencephaly (HPE), a craniofacial malformation, results from flaws in formation process of the nervous system during embryonic development. The etiology is heterogeneous and complex, involving environmental and genetic factors. Recent studies suggest that subtelomeric aberrations could be an etiological factor to the onset of HPE. Objectives: Investigate possible changes (microdeletions/duplications) in subtelomeric regions in individuals diagnosed with HPE. Methodology: Genetic evaluation of 25 DNA samples from individuals enrolled at HRAC-USP, diagnosed with HPE (performed by Syndromology Division HRAC/USP) by MLPA technique, as proposed by Schouten et al (2002). Patients were previously screened for mutations/deletions in HPE candidate genes (SHH ZIC2, TGIF, GLI2 and PTCH1) by direct Sanger sequencing and MLPA technique, without any match. Analyses were performed at the Laboratory of Molecular Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, HRAC-USP. Results: Among the 25 individuals analyzed, the predominant phenotype was HPE microform. The main clinical findings of the study sample were: hypotelorism, microcephaly, and cleft lip/palate (100%); flat nose (84%); presence of a single central incisor (24%) and low nasal bridge (64%). Four patients had CNS commitment (16%). No subtelomeric mutations were found in our sample, such as microdeletions/duplications of genes analyzed by MLPA technique. Thus, they remain without defined genetic diagnosis. Discussion: Subtelomeric changes were not found, suggesting that the predominant sample phenotype, microform HPE, could not be related with subtelomeric changes associated to the disease outbreak. However, it should be noted that the sample universe is relatively small, so this may not be a true example of HPE microform cases. It should also be reinforced the wide variety of factors involved in the onset of this pathology, as well as the involvement of other genes not yet established and environmental causes, not completely understood. Conclusions: No subtelomeric mutations were found in the HPE individuals studied. MLPA technique consists in a rapid, sensitive and cost effective methodology, when compared to other techniques being suitable for use in genetic diagnostic laboratories, since several studies have shown that consists of a reliable method of diagnosis. Due to the relatively small sample size used in this study, and even inconsistent data in literature, further studies are needed to make it possible to perform a differential diagnosis, explaining the wide phenotypic spectrum observed in this disease, as suggested by the multiple hit hypothesis.
Lindberg, Magdalena. "Utökning av panelför multiplex RT-MLPA av singel celler för prostatacancer diagnostik." Thesis, KTH, Skolan för bioteknologi (BIO), 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-173122.
Full textProstatacancer är den vanligaste cancerformen hos män. Att räkna antal cirkulerade tumörceller (CTCer) i blodet är ett bra verktyg för att undersöka hur sjukdomen fortlöper och hur den svarar på behandling. CTCer är enskilda celler som brutit sig loss från originaltrumören och sprids i kroppen genom blodsystemet. I det här examensarbetet analyseras en panel bestående av 16 gener med hjälp av Reverse Transcriptase Multiplexed Ligation-dependent Probe Amplification (RT-MLPA). Metoden bygger på att genspecifika primrar används för att syntetisera cDNA från mRNA. MLPA-prober hybridisear sedan till det amplifierade cDNAt. MLPA prober som hybridiserat korrekt ligeras och amplifieras och den relativa uttrycksnivåerna kan beräknas. Ytterligare en MLPA-probe designades för att passa in i den existerande blandningen av MLPA-prober. Resultaten viar att alla MLPA-prober ger produkter då en syntetisk DNA-templat blandning med lika koncentrationer används. Resultaten från total-RNA från cellinjer visar att omvandlingen och amplifieringen av mRNA till cDNA måste optimeras. När hela protokollet fungerar är det möjligt att undersöka genuttrycken i CTCer vilket kan underlätta förståelsen för utveckling och spridning av prostatacancer i kroppen.
Nascimento, Juliana Minuncio. "Análise do perfil de mutações driver por MLPA em pacientes com Mielofibrose." reponame:Repositório Institucional da UnB, 2017. http://repositorio.unb.br/handle/10482/31249.
Full textSubmitted by Raquel Viana (raquelviana@bce.unb.br) on 2018-02-16T18:16:36Z No. of bitstreams: 1 2017_JulianaMinuncioNascimento.pdf: 2253571 bytes, checksum: b4527c088c7b8285e11c0f28fe5c865e (MD5)
Approved for entry into archive by Raquel Viana (raquelviana@bce.unb.br) on 2018-02-16T18:17:17Z (GMT) No. of bitstreams: 1 2017_JulianaMinuncioNascimento.pdf: 2253571 bytes, checksum: b4527c088c7b8285e11c0f28fe5c865e (MD5)
Made available in DSpace on 2018-02-16T18:17:17Z (GMT). No. of bitstreams: 1 2017_JulianaMinuncioNascimento.pdf: 2253571 bytes, checksum: b4527c088c7b8285e11c0f28fe5c865e (MD5) Previous issue date: 2018-02-16
A Mielofibrose é a mais rara e severa das Neoplasias Mieloproliferativas Crônicas Philadelphia negativas. Caracteriza-se por fibrose medular, hematopoese extramedular e expressão anormal de citocinas inflamatórias, que resultam em citopenias, organomegalias, sintomas constitucionais, eventos trombohemorrágicos e evolução para Leucemia Aguda. Pode ocorrer de novo ou pós Policitemia Vera ou Trombocitemia Essencial, a partir da expansão clonal de uma célula tronco hematopoética desencadeada por uma mutação somática envolvendo os genes JAK2, CALR ou MPL, combinada a desregulação dos nichos hematopoéticos, a mutações e a anomalias citogenéticas adicionais. Este estudo visou caracterizar o perfil de mutações driver de portadores de Mielofibrose primária e secundária acompanhados em um serviço público terciário de Hematologia, e correlacionar este perfil aos desfechos clínicos dos doentes. A pesquisa das mutações JAK2 V617F (éxon 14) e éxon 12, CALR c.1092_1143del52 e c.1154_1155insTTGTC (éxon 9) e MPL W515K e W515L foi realizada em 31 indivíduos por meio da técnica de MLPA, método de análise de DNA que permite a pesquisa simultânea de diferentes mutações, em diferentes amostras. A mutação JAK2V617F foi encontrada em 48,4% dos pacientes, mutações indel do éxon 9 da CALR em 38,7% (em 66,7% destes a mutação del52, e em 33,3% a mutação insTTGTC), e a mutação MPL W515L em 3,2% dos pacientes. 9,7% dos pacientes eram triplo-negativos. Os pacientes com JAK2 mutada eram mais idosos, com menor grau de anemia e maior frequência de leucocitose, enquanto os portadores de mutações da CALR apresentavam menor frequência de leucocitose e plaquetopenia. Os indivíduos triplo-negativos apresentaram a menor mediana de idade ao diagnóstico (49,3 anos) e fenótipo de falência medular semelhante a Síndrome Mielodisplásica. A estratificação de risco por DIPSS foi semelhante à relatada em outros centros. O tempo mediano de acompanhamento foi de 32 meses (variando de 10 meses a 13 anos), sendo registrados fenômenos tromboembólicos em 19,3% e evolução para LMA em 6,4% dos pacientes. A taxa de mortalidade foi de 29%, e a sobrevida média após o diagnóstico foi de 68,3 meses. Os indivíduos com mutação da CALR apresentaram maior sobrevida média. A mediana de sobrevida de acordo com o DIPSS foi superior à prevista pelo modelo prognóstico, possivelmente pela maior frequência de mutações da CALR observada nesta população. Maior tempo de seguimento e inclusão de novos pacientes são necessários para melhor avaliação de desfechos e confirmação da maior prevalência de mutações da CALR. A pesquisa de mutações driver é essencial para sustentação diagnóstica, define subgrupos de doentes com características clínicas peculiares e, aliada a pesquisa de mutações colaborativas, tem impacto prognóstico. O complexo panorama genético envolvido na iniciação e progressão das NMP, especialmente a Mielofibrose, instiga a adoção de modelos integrativos de estratificação prognóstica. Neste cenário, o MLPA é uma potente ferramenta para estudo molecular, e um promissor aliado na caracterização das NMP.
Myelofibrosis is the rarest and most severe Philadelphia-negative myeloproliferative neoplasm and can present de novo or post Polycythemia Vera or Essential Thrombocythemia. It is characterized by bone marrow fibrosis, extramedullary hematopoiesis and abnormal expression of inflammatory cytokines, which result in cytopenias, organomegaly, constitutional symptoms, thrombohemorrhagic events and progression to Acute Leukemia. The disease arises from clonal expansion of a single hematopoietic stem cell (HSC), driven by a somatic mutation of JAK2, CALR or MPL genes combined with dysregulation of hematopoietic microenvironment, additional mutations and cytogenetic abnormalities. This study aimed to assess driver mutations status in patients with primary and secondary myelofibrosis accompanied at a tertiary Brazilian public hospital, and to correlate their mutational profile with clinical outcomes. The search for JAK2V617F, exon 12 JAK2, calreticulin exon 9 c.1092_1143del52 and c.1154_1155insTTGT, MPLW515K and MPLW515L mutations was performed in 31 subjects using MLPA technique, a method of DNA analysis that allows simultaneous appraisal of different mutations in multiple samples. JAK2V617F mutation was found in 48.4% of patients, indel CALR mutations in 38.7% of patients (of these, 66.7% harbored del52 bp, 33.3% harbored insTTGTC), MPL W515L in 3.2% of patients and 9.7% of patients were triple-negative. Patients with mutated JAK2 were older, with minor degree of anemia and more leukocytosis, whereas those with CALR mutations had less frequency of leukocytosis and thrombocytopenia. Triple-negative subjects displayed the lowest median age at diagnosis (49.3 years), and bone marrow failure phenotype, similar to Myelodysplastic Syndrome. Risk stratification provided by DIPSS was similar to other centers. Median follow-up time was 32 months (ranging from 10 months to 13 years). Thromboembolic phenomena were recorded in 19.3% of patients, and evolution to AML in 6.4% of patients. Mortality rate was 29%, and mean survival after diagnosis was 68.3 months. CALR mutated individuals presented higher average survival. Median survival according to DIPSS was higher than predicted by the prognostic model, possibly due to the higher frequency of CALR mutations reported. Longer follow-up and inclusion of new patients are necessary for better evaluation of outcomes and confirmation of the higher prevalence of CALR mutations. Driver mutations assessment is essential for diagnostic support, defines subgroups with peculiar clinical characteristics and, combined with collaborative mutations evaluation, has prognostic impact. The complex genetic landscape involved in initiation and progression of MPN, especially Myelofibrosis, instigates the adoption of integrative prognostic stratification models. In this scenario, MLPA is a powerful tool for molecular study, and a promising ally for MPN molecular characterization.
Jun, M. S. "Governing Marine Protected Areas (MPAs) in California : analysis of the MLPA implementation process." Thesis, University College London (University of London), 2014. http://discovery.ucl.ac.uk/1427878/.
Full textMoura, Karla Cristina Vasconcelos. "Relação entre fatores genéticos envolvidos em vias metabólicas mitocondriais e a doença de Parkinson." Universidade do Estado do Rio de Janeiro, 2013. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=6826.
Full textA doença de Parkinson (DP) é uma das desordens neurodegenerativas mais comuns associada ao envelhecimento, alcançando 2% aos 70 anos. É uma doença caracterizada pela degeneração progressiva de neurônios dopaminérgicos nigrais nos gânglios basais e pela presença de inclusões protéicas citoplasmáticas denominadas corpúsculos e neuritos de Lewy nos neurônios sobreviventes. A etiologia da DP é pouco conhecida, sendo considerada, na maioria dos casos, idiopática. Conhecimentos alcançados nos últimos 15 anos sobre a base genética da DP demonstram, claramente, que os fatores genéticos desempenham um importante papel na etiologia desta desordem. Neste trabalho, rastreamos mutações nos genes que codificam proteínas participantes de vias metabólicas mitocondriais (Parkin, PINK1 e DJ-1) em 136 pacientes brasileiros com manifestação precoce da DP, através do sequenciamento automático e da técnica de MLPA. Avaliamos a presença de variantes de sequência por meio do sequenciamento dos exons 1 a 12 do gene Parkin e dos exons 1 a 8 do gene PINK1. Em Parkin foram identificadas três mutações patogênicas ou potencialmente patogênicas, ambas em heterozigose: p.T240M, p.437L e p.S145N. Em PINK1 não encontramos variantes de ponto patogênicas. Através da técnica de MLPA investigamos alterações de dosagem nos genes Parkin, PINK1 e DJ-1. Identificamos cinco alterações no gene Parkin em quatro pacientes: uma duplicação heterozigota do exon 4 no paciente PAR2256, uma deleção heterozigota do exon 4 no probando PAR2099, uma deleção homozigota do exon 4 na paciente PAR3380 e um probando heterozigoto composto (PAR2396) com duas alterações, uma duplicação do exon 3 e uma deleção dos exons 5 e 6. No gene PINK1 identificamos uma deleção heterozigota do exon 1, que nunca foi descrita na literatura, em um paciente (PAR2083). Não encontramos alteração quantitativa no gene DJ-1. Neste estudo obtivemos uma frequência total de mutações patogênicas (pontuais e de dosagem) nos genes estudados de 7,3%, sendo 6,6% no gene Parkin e 0,7% no gene PINK1.
Parkinson's disease (PD) is one of the most common neurodegenerative disorders associated with aging, reaching 2% at age 70. It is a disease characterized by progressive degeneration of nigra dopaminergic neurons in the basal ganglia and the presence of cytoplasmic protein inclusions known as Lewy bodies and neurites in surviving neurons. The etiology of PD is poorly understood, being considered, in most cases, idiopathic. Knowledge achieved in the last 15 years about the genetic basis of PD clearly shows that genetic factors play an important role in the etiology of this disorder. In this study, we screened mutations in genes that encode proteins participating in mitochondrial metabolic pathways (Parkin, PINK1 and DJ-1) in 136 Brazilian patients with early onset PD, through automatic sequencing and MLPA technique. We evaluated the presence of sequence variants by means of sequencing of exons 1 to 12 of Parkin gene and exons 1 to 8 of PINK1 gene. In Parkin gene were identified three pathogenic or potentially pathogenic mutations, both in heterozygous state: p.T240M, p.437L e p.S145N. In PINK1 gene we did not find pathogenic point mutations. Through the MLPA technique we investigated dosage changes in Parkin, PINK1 and DJ-1 genes. We identified five exon rearrangements in Parkin gene in four patients: a heterozygous duplication of exon 4 in patient PAR2256, a heterozygous deletion of exon 4 in proband PAR2099, a homozygous deletion of exon 4 in patient PAR3380 and a compound heterozygote (PAR2396) with two changes, a duplication of exon 3 and a deletion of exons 5 and 6. In PINK1 gene we identified a heterozygous deletion of exon 1, which has never been described in literature, in one patient (PAR2083). We found no quantitative change in DJ-1 gene. In this study, we obtained an overall frequency of pathogenic mutations (sequence and dosage) in the genes studied of 7.3%, being 6.6% in Parkin gene and 0.7% in PINK1 gene.
Suemasu, Cintia Natsumi. "Caracterização dos genótipos da talassemia alfa delecional por MLPA (Multiplex Ligation-Dependent Probe Amplification)." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308947.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-16T20:41:19Z (GMT). No. of bitstreams: 1 Suemasu_CintiaNatsumi_M.pdf: 6481597 bytes, checksum: f9093ca98b4efb60bfe4f81a7e80efee (MD5) Previous issue date: 2010
Resumo: A talassemia alfa (a) constitui um grupo de doenças hereditárias causadas pela redução ou ausência da síntese das cadeias 'alfa' da hemoglobina. Os genes responsáveis pela codificação dessas cadeias são duplicados ('alfa' 2 e 'alfa'1) e estão localizados em um agrupamento gênico ou cluster, situado próximo ao telômero do cromossomo 16 (16p13.3). As deleções são as principais causas da doença, podendo afetar um ou ambos os genes 'alfa' do cromossomo (formas 'alfa' + e 'alfa' 0, respectivamente). Nos últimos anos, várias técnicas foram desenvolvidas para identificar as deleções envolvendo o cluster dos genes a no cromossomo 16. A gap- PCR, o Southern blot e o FISH são comumente aplicados com esta finalidade; entretanto, muitas deleções ainda não são detectadas utilizando-se essas estratégias metodológicas. Em 2005, uma técnica simples e adequada a análises quantitativas rápidas, o Multiplex Ligation-dependent Probe Amplification (MLPA), foi adaptada ao diagnóstico das hemoglobinopatias. Esta técnica é baseada na ligação e na amplificação, em reação de PCR, de dois oligonucleotídeos (sondas) que se hibridizam de forma adjacente ao DNA alvo. Cada oligonucleotídeo é projetado para gerar um produto de comprimento único e, por possuírem terminações comuns, todas as sondas podem ser amplificadas utilizando um único par de iniciadores. Por fim, o uso de fluorocromos permite a separação dos fragmentos, que foram gerados pela amplificação das sondas, em sistema de seqüenciamento por capilaridade. No presente estudo nós utilizamos o MLPA para investigar as bases moleculares da talassemia alfa em nove pacientes não relacionados, cinco deles com Doença da Hb H, cujos diagnósticos moleculares não puderam ser esclarecidos pelas técnicas usuais, incluindo o seqüenciamento de DNA. No total, foram utilizadas 44 sondas, distribuídas desde o telômero ao gene MSLN, cobrindo uma região de cerca de 800 kb, na região 16p13.3. Oito diferentes deleções foram detectadas. Enquanto quatro delas comprometem uma região de grande extensão que inclui todo o locus a e seu elemento regulatório, com tamanhos mínimos de 240 kb, 470 kb, 500 kb e 720 kb, respectivamente (posições 97000-334571, 97000-570532, 97000-602492 and 97000- 816477 do UCSC Genome Browser, Fevereiro, 2009, respectivamente), quatro outras encontram-se limitadas às regiões que contém o elemento regulatório, deixando os genes a intactos, porém sem expressão. Essas últimas apresentam tamanhos mínimos de 0.4 kb, em um dos casos, e de 95 kb a 100 kb nos demais (posições entre 163464-163904, 97000- 193847, 97000-202417 e 97000-202417 do UCSC Genome Browser, Fevereiro, 2009, respectivamente). Em um dos pacientes com fenótipo talassêmico heterozigótico foi demonstrada a presença de uma quadruplicação de cerca de 230 kb de DNA, incluindo todo o cluster a e seu elemento regulatório (97000 a 231370 do UCSC Genome Browser, Fevereiro, 2009). Este estudo representa o primeiro no Brasil a empregar o método de MLPA na caracterização das bases moleculares da talassemia a. A ampla diversidade de alterações identificadas enfatiza a necessidade de se investigar todos os casos cujos valores hematológicos revelem hipocromia e microcitose, na ausência de deficiência de ferro e níveis normais de HbA2
Abstract: Alpha (a) thalassemia is an inherited hemoglobin disorder characterized by reduction or absence of the a-globin chain synthesis. These chains are encoded by duplicated genes ('alpha' 2 and 'alpha' 1) that lie in a gene cluster near the telomeric end of the short arm of chromosome 16 (16p13.3). Deletions are the major molecular cause of the disease and may affect one or both 'alfa genes in the chromosome (the 'alpha' + and 'alpha' 0 forms, respectively). In recent years several techniques have been developed to identify deletions involving the 'alpha' -globin cluster in chromosome 16. The molecular tests commonly used to identify these deletions are gap- PCR, Southern Blot analysis and FISH. However, several thalassemia deletions remain uncharacterized by these methods. In 2005 a simple technique suitable for rapid quantitative analysis ¾ multiplex ligationdependent probe amplification (MLPA) ¾ was adapted for the diagnosis of thalassemias. The approach is based on the ligation and PCR amplification of two adjacently hybridizing oligonucleotides (probes). Each oligonucleotide pair is designed to give a product of unique length, and by using common ends all the probes can be amplified with one primer pair. Finally, the use of a fluorescent label allows the probe to be separated in a capillary sequencing system. In this study we used MLPA to investigate the molecular basis of thalassemia in nine unrelated patients (five with Hb H disease) in whom the molecular causes of the disease could not be detected by sequence analysis or other conventional techniques. In total, 44 probe pairs were used, covering approximately 800 kb from the telomere to the MSLN gene in the 16p13.3 region. Eight different deletions were detected. While four of them affect a large region including the entire ? -globin gene locus and its upstream regulatory element, spanning genomic regions of at least 240 kb, 470 kb, 500 kb and 720 kb (positions 97000-334571, 97000-570532, 97000-602492 and 97000-816477 of the UCSC Genome Browser, February, 2009, respectively). The other four deletions were limited to a region that contains the upstream regulatory element; the ? -globin genes, although intact, are therefore not expressed. These deletions span a region of at least 0.4 kb in one case and from 95 kb to 100 kb in the other cases (positions 163464-163904, 97000- 193847, 97000-202417 and 97000-202417 of the UCSC Genome Browser, February, 2009, respectively). One carrier who was suspected of having heterozygous ? -thalassemia showed a segmental quadruplication spanning about 230 kb and including the a cluster and upstream regulatory element (97000-231370 do UCSC Genome Browser, February, 2009). This study is the first in Brazil to use the MLPA method to characterize thalassemias. The variety of rearrangements identified highlights the need to investigate all cases presenting with microcytosis and hypochromia without iron deficiency or elevated Hb A2 levels
Mestrado
Ciencias Biomedicas
Mestre em Ciências Médicas
Cuevas, Sánchez Dolors. "Aplicació de tecnologies d’alt rendiment per a l’anàlisi d’alteracions moleculars i l’heterogeneïtat intratumoral en el càncer d’endometri." Doctoral thesis, Universitat de Lleida, 2020. http://hdl.handle.net/10803/670256.
Full textLos dos subtipos más frecuentes de cáncer de endometrio (CE) son el carcinoma endometrioide (CEE) y el carcinoma seroso (CSE). El diagnóstico diferencial entre estas dos tipologías no siempre es fácil, hay casos que presentan características histológicas muy dudosas y ambiguas que dificultan su correcto diagnóstico final. Estos dos tipos tumorales presentan perfiles moleculares y pronósticos diferenciales, haciendo que el CSE sea el subtipo más agresivo y con el pronóstico más desfavorable. Actualmente se está poniendo en conocimiento la importancia que puede jugar la heterogeneidad intratumoral (HIT) en los comportamientos más agresivos de los tumores y en la resistencia a los tratamientos, como es el caso del CSE. En los últimos años, la irrupción de las tecnologías de alto rendimiento como la NGS (Next Generation Sequencing) y la MLPA (Multiple Ligase-dependiente Probe Amplification) han ofrecido la opción de ampliar el conocimiento molecular del cáncer de una manera más precisa y resolutiva. Por estos motivos, los dos primeros objetivos de esta tesis se han centrado en analizar en los dos tipos más frecuentes de cáncer de endometrio varias alteraciones moleculares que nos permitan obtener unos perfiles genéticos específicos, y clasificar de una manera más precisa y objetiva estos dos tipos tumorales. Para realizar los análisis de las alteraciones genéticas se han utilizado, la aplicación de targeted sequencing (NGS) con un panel personalizado de 40 genes para determinar los genes alterados respecto a variantes somáticas, y la técnica MLPA para determinar las alteraciones somáticas en el número de copias (ASNC) de 106 genes. Finalmente, el tercer objetivo se ha focalizado en conocer el papel que juega la heterogeneidad intratumoral en el CSE. El efecto de la HIT ha sido estudiado a dos niveles de alteración molecular, a nivel de la alteración de los genes analizando las variantes somáticas y la alteración en el número de copias de los genes, mediante las dos técnicas anteriores. Los resultados del primer objetivo de esta tesis han demostrado la idoneidad de nuestro estudio personalizado de NGS como herramienta molecular adicional para confirmar la clasificación histológica del CE. Esta estrategia parece interesante como una herramienta para clasificar tumores con hallazgos microscópicos inusuales y ambiguos. Con los resultados del segundo objetivo se ha descrito que de manera general el CSE presenta muchas más ASNC que el CEE. Sin embargo, también se ha mostrado que dentro el CSE hay un porcentaje de casos (42%) que presentan unas características genéticas que no corresponden con el fenotipo, por lo que en estos casos puede ser de gran ayuda el uso del perfil genético de ASNC para realizar una clasificación más correcta. Además, se ha sugerido el uso de la combinación de la determinación de p53 por inmunohistoquímica y del número de copias de la CCNE1 para clasificar los casos dentro del grupo serous-like. Para finalizar, los resultados del tercer objetivo han mostrado que el CSE, por una parte, presenta unas alteraciones moleculares clonales como las variantes somáticas en el gen TP53 y ganancias en los genes CCNE1 y PIK3CA, y por otra parte, que su heterogeneidad intratumoral está caracterizada principalmente por las ASNC de los genes. Además, se ha remarcado que uno de los genes principalmente afectados por esta heterogeneidad es el gen ERBB2, que es una diana terapéutica ampliamente utilizada.
The two most common subtypes of endometrial cancer (CE) are endometrioid carcinoma (CEE) and serous carcinoma (CSE). Differential diagnosis between these two types is not always easy, there are cases with very doubtful and ambiguous histological features that make it difficult their final diagnostic. These two tumor types have different molecular profiles and differential prognosis, making the CSE the most aggressive subtype and with the most unfavorable prognosis. At present, the importance of intratumoral heterogeneity (HIT) can be played out in the most aggressive behaviors of tumors and in resistance to treatment, as in the case of CSE. In recent years, the advent of high-performance technologies such as NGS (Next Generation Sequencing) and MLPA (Multiple Ligase-dependent Probe Amplification) have offered the option of extending molecular knowledge of cancer in a way more accurate and resolute. For these reasons, the first two objectives of this dissertation have been to analyze in the two most common types of endometrial cancer, various molecular alterations that allow us to obtain specific genetic profiles, and to classify more precisely and objective these tumor types. To preform genetic alteration analyzes have been used the application of targeted sequencing (NGS) with a personalized panel of 40 genes to determine the altered genes with respect to somatic variants, and the MLPA technique to determine somatic alterations in the number of copies (ASNC) of 106 genes. Finally, the third objective was focused on understanding the role that intratumoral heterogeneity plays in CSE. The effect of HIT has been studied at two levels of molecular alteration, at the level of the genes determining somatic variants and the number of copies of the genes, using the two previous techniques. The results of the first objective of this thesis have shown the suitability of our personalized NGS study as an additional molecular tool to confirm the histological classification of CE. This strategy seems interesting as a tool for classifying tumors with unusual and ambiguous microscopic findings. The results of the second objective have described that in general the CSE has many more ASNCs than the EEC. However, it has also been shown that in the CSE there is a percentage of cases (42%) that have genetic characteristics that do not correspond to the phenotype, and therefore in these cases the use may be very helpful of the ASNC gene profile for more accurate classification. In addition, the combination of p53 determination by immunohistochemistry and the number of CCNE1 copies has been suggested to classify cases within the group serous-like. Finally, the results of the third objective have shown that CSE, on the one hand, has clonal molecular alterations such as the somatic variants in the TP53 gene and gains in the CCNE1 and PIK3CA genes, and on the other hand, that its intratumoral heterogeneity is characterized mainly by the ASNC of the genes. It has also been emphasized that one of the genes that is most affected by this heterogeneity is the ERBB2 gene, which is a widely used therapeutic target.
Murray, Michael S. "The genetic analysis of mlpA, a gene encoding a myosin-like protein in Physarum polycephalum." Thesis, University of Leicester, 1990. http://hdl.handle.net/2381/34453.
Full textUehara, Daniela Tiaki. "Pesquisa de microrrearranjos em genes candidatos a surdez sindrômica e não-sindrômica." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/41/41131/tde-22022011-111240/.
Full textSeveral genes contribute to the complexity of physiology of hearing. Consequently, hereditary deafness is extremely heterogeneous from the genetic point of view. In the last two decades, several genes responsible for hereditary hearing loss have been identified, but a large number of genes remains to be found, as evidenced by the unexplained cases of inherited deafness. The search for point mutations in candidate genes after mapping based on linkage studies has been the main strategy in the identification of such genes. Other mutation mechanisms, such as deletions and duplications, have been rarely investigated, and the contribution of DNA copy number variants (CNVs) to hearing loss is not well known. This study aimed at identifying novel genes, which might play a role in the etiology of syndromic and non-syndromic deafness, through the search of gene microdeletions and microduplications. We selected 25 candidate genes (CTTN, FGF3, FGF19, FOXC1, FOXF2, FOXQ1, IMMP2L, KIF5C, LRRN3, MAP1A, MYLK4, PPP3CA, SHANK2, SLC5A7, STRC, TMC1, TMC2, TMC3, TMC4, TMC5, TMC6, TMC7, TMC8, TPCN2 and TUBB2A) based on their involvement in microimbalances detected by Array-based Comparative Genomic Hybridization (aCGH) in a previous study of a Brazilian sample of individuals with syndromic hearing loss from our laboratory and others reported in the literature. We studied 163 subjects, 74 of them presenting syndromic deafness, the majority were isolated cases, and 89 being probands of families in which nonsyndromic deafness had an autosomal dominant or recessive mode of inheritance. Gene deletions or duplications were screened by Multiplex Ligant-dependent Probe Amplification (MLPA) using one synthetic intragenic probe designed for each candidate gene. We detected six deletions in TMC6 (3,7%), six deletions and one duplication in STRC (4,3%), and one duplication in IMMP2L (0,6%). The screening of imbalances in these genes in a control sample of 189 hearing individuals revealed four deletions in TMC6 (2,1%), eight deletions and three duplications in STRC (5,8%) and three deletions in IMMP2L (1,6%). The imbalances found in TMC6, both in affected and control individuals, were in fact artifacts due to problems in the hybridization of the corresponding probe. As to the STRC gene, previously related to deafness, the imbalances are more likely to be 4 polymorphisms with no phenotypic effect. However, the possibility remains that additional undetected mutations in affected individuals contribute to their phenotype, in combination with the microrearrangement, as already reported in the literature. The duplication in IMMP2L in a non-syndromic patient, and also present in her affected mother, is most likely causative of deafness, since a complementary study performed with aCGH revealed that the rearrangement included a partial duplication of the 3 end of another gene, DOCK4. An isoform of the DOCK4 protein localizes to the stereocilia in the inner ear and interacts with harmonin, a protein already known to be involved in hearing. We hypothesize that this duplication may be the cause of deafness in the family and, this being the case, DOCK4 appears as a novel deafness gene. The causal association between IMMP2L and deafness is less plausible, because of the large number of reported non-pathogenic CNVs that include parts of this gene. Further studies are required to precisely map this duplication. In addition, the screening of mutations in DOCK4 in other families with hearing impairment is required to evaluate its possible role in the etiology of deafness.
Goveia, Rebeca Mota. "Análise de deleção/ duplicação nos genes BRCA1 e BRCA2 em pacientes de Goiás-Brasil com suspeita da síndrome do câncer de mama e ovário hereditário." Universidade Federal de Goiás, 2018. http://repositorio.bc.ufg.br/tede/handle/tede/8723.
Full textApproved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-07-19T11:18:57Z (GMT) No. of bitstreams: 2 Dissertação - Rebeca Mota Goveia - 2018.pdf: 2457051 bytes, checksum: 721dc25f2c29d54fc3bd4f0f13c5fc83 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Made available in DSpace on 2018-07-19T11:18:57Z (GMT). No. of bitstreams: 2 Dissertação - Rebeca Mota Goveia - 2018.pdf: 2457051 bytes, checksum: 721dc25f2c29d54fc3bd4f0f13c5fc83 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2018-03-07
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
Introduction: Breast cancer is the second most common cancer in the world, and the most common among women, only 5% to 10% are hereditary and half of them are caused by hereditary breast and ovarian cancer (HBOC) , caused by variations in the BRCA1 and BRCA2 genes. Objectives: The present study aimed to identify the prevalence of deletions and duplications in BRCA1 and BRCA2 genes in breast cancer patients in Goiás, Brazil. Materials and methods: We evaluated 46 breast cancer patients who met National Comprehensive Cancer Network (NCCN) criteria for HBOC syndrome screening. A 4 ml blood sample was collected for DNA extraction using commercial kit and the MLPA (Multiplex Ligation Dependent Probe Amplification) technique was performed using the SALSA MLPA P002 BRCA1 and SALSA MLPA P045 BRCA2 / CHECK2 kits. Results and discussion: The majority of the patients were female (97.83%) and the mean age of the patients was 37.52 years. In this group, 43.47% of the patients were younger than 35 years at the time of diagnosis and 35% of them were diagnosed with triple negative tumors. The most common molecular subtype was luminal A (46.2%) followed by triple negative tumors (28.20%). No patient was found with rearrangements in BRCA1. In the BRCA2 gene, one patient (2.12%) presented a false positive result for the heterozygous deletion of exon 27, which may have been caused by the presence of a small change in the probe binding region. Conclusion: This was the first study performed to analyze large deletions and duplications in patients from the central-western region of Brazil. We can conclude that the frequency of large deletions and duplications in the BRCA1 and BRCA2 genes in the Goian population is low.
Introdução: O câncer de mama é o segundo tipo de câncer mais freqüente no mundo, e o mais comum entre as mulheres, apenas 5% a 10% são hereditários e metade deles são causados pela síndrome do câncer de mama e ovário hereditário (HBOC), causada por variações nos genes BRCA1 e BRCA2. Objetivos: O presente estudo teve como objetivo identificar a prevalência de deleções e duplicações nos genes BRCA1 e BRCA2 em pacientes com câncer de mama no estado de Goiás, Brasil. Materiais e métodos: Avaliamos 46 pacientes com câncer de mama que atenderam aos critérios do National Comprehensive Cancer Network (NCCN) para pesquisa da síndrome HBOC. Foi coletada uma amostra de sangue de 4 ml para extração de DNA usando kit comercial e a técnica MLPA (Multiplex Ligation Dependent Probe Amplification) foi realizada usando os kits SALSA MLPA P002 BRCA1 e SALSA MLPA P045 BRCA2 / CHECK2. Resultados e discussão: A maioria dos pacientes era do sexo feminino (97.83%) e a idade média dos pacientes era de 37,52 anos. Neste grupo 43.47% dos pacientes possuíam idade inferior a 35 anos no momento do diagnóstico sendo que 35% destes foram diagnosticados com tumores triplo negativo. O subtipo molecular mais comum foi o luminal A (46.2%) seguido de tumores triplo negativos (28.20%). Nenhum paciente foi encontrado com rearranjos no gene BRCA1. No gene BRCA2, um paciente (2,12%) apresentou um resultado falso positivo para a deleção em heterozigoze do éxon 27, fato que pode ter sido ocasionado pela presença de uma pequena alteração na região de ligação da sonda. Conclusão: Este foi o primeiro estudo realizado para análise de grandes deleções e duplicações em pacientes da região centro-oeste do Brasil. Podemos concluir que a frequência de grandes deleções e duplicações nos genes BRCA1 e BRCA2 na população goiana é baixa.
Books on the topic "MLPANN"
Manners Look Pretty on You: Mlpon. Independently Published, 2020.
Find full textTeam, The Examelot. MLPAO MLA/T Certification Exam: Practice Test 1. Independently Published, 2020.
Find full textTeam, The Examelot. MLPAO MLA/T Certification Exam: Practice Test 2. Independently Published, 2020.
Find full textMLPAO MLA/T Certification Exam: Practice Test 5. Independently Published, 2021.
Find full textTeam, The Examelot. MLPAO MLA/T Certification Exam: Practice Test 4. Independently Published, 2021.
Find full textBook chapters on the topic "MLPANN"
Arnemann, J. "MLPA." In Springer Reference Medizin, 1669–70. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_3533.
Full textArnemann, J. "MLPA." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_3533-1.
Full textMohapatra, Sushree Shataroopa, Manoj Kumar Maharana, Abhilash Pradhan, P. K. Panigrahi, and R. C. Prusty. "Islanding Detection in Distributed Generation System Using MLPNN and ELPID Methods." In Smart Technologies for Power and Green Energy, 211–21. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2764-5_18.
Full textJha, Panchanand, Bibhuti Bhusan Biswal, and Om Prakash Sahu. "Intelligent Computation of Inverse Kinematics of a 5-dof Manipulator Using MLPNN." In Advances in Autonomous Robotics Systems, 243–50. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-10401-0_22.
Full textOhnesorg, Thomas, Erin Turbitt, and Stefan J. White. "The Many Faces of MLPA." In Methods in Molecular Biology, 193–205. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-944-4_13.
Full textBerbegall, Ana Pilar, Eva Villamón, Samuel Navarro, and Rosa Noguera. "Multiplex Ligation-dependent Probe Amplification (MLPA)." In Guidelines for Molecular Analysis in Archive Tissues, 215–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-17890-0_33.
Full textOhnesorg, Thomas, Stefanie Eggers, and Stefan J. White. "Detecting DNaseI-Hypersensitivity Sites with MLPA." In Methods in Molecular Biology, 201–10. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-292-2_12.
Full textMahesh, Vijayalakshmi G. V., Alex Noel Joseph Raj, and P. Arulmozhivarman. "Thermal IR Face Recognition Using Zernike Moments and Multi Layer Perceptron Neural Network (MLPNN) Classifier." In Advances in Intelligent Systems and Computing, 213–22. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-60618-7_21.
Full textSchouten, Jan, and Robert-Jan Galjaard. "MLPA for Prenatal Diagnosis of Commonly Occurring Aneuploidies." In Prenatal Diagnosis, 111–22. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-066-9_8.
Full textMoelans, Cathy B., Lilit Atanesyan, Suvi P. Savola, and Paul J. van Diest. "Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA)." In Methods in Molecular Biology, 537–49. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7481-8_27.
Full textConference papers on the topic "MLPANN"
Tahamipour-Z., S. Mohammad, Iman Kardan, Hadi Kalani, and Alireza Akbarzadeh. "A PSO-MLPANN Hybrid Approach for Estimation of Human Joint Torques from sEMG Signals." In 2020 8th Iranian Joint Congress on Fuzzy and intelligent Systems (CFIS). IEEE, 2020. http://dx.doi.org/10.1109/cfis49607.2020.9238724.
Full textMiano, Carlo M., Massimiliano Gobbi, and Giampiero Mastinu. "A Tutorial on Present and Future Global Approximation Issues With Application to a Vehicle Design Problem." In ASME 2001 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2001. http://dx.doi.org/10.1115/imece2001/de-23264.
Full textVerma, Alka, and J. N. Mathur. "An Examination on Intelligent Islanding Classification with MLPNN." In 2022 Fourth International Conference on Emerging Research in Electronics, Computer Science and Technology (ICERECT). IEEE, 2022. http://dx.doi.org/10.1109/icerect56837.2022.10060600.
Full textFrimpong, Emmanuel Asuming, Philip Yaw Okyere, and Johnson Asumadu. "On-line determination of transient stability status using MLPNN." In 2017 IEEE PES/IAS PowerAfrica. IEEE, 2017. http://dx.doi.org/10.1109/powerafrica.2017.7991194.
Full textKatiyar, Gauri, and Shabana Mehfuz. "MLPNN based handwritten character recognition using combined feature extraction." In 2015 International Conference on Computing, Communication & Automation (ICCCA). IEEE, 2015. http://dx.doi.org/10.1109/ccaa.2015.7148550.
Full textRuslan, Fazlina Ahmat, Abd Manan Samad, Mazidah Tajuddin, and Ramli Adnan. "Flood prediction modeling using improved MLPNN structure: Case study Kuala Lumpur." In 2015 IEEE Conference on Systems, Process and Control (ICSPC). IEEE, 2015. http://dx.doi.org/10.1109/spc.2015.7473567.
Full textTagougui, Najiba, Houcine Boubaker, Monji Kherallah, and Adel M. Alimi. "A hybrid MLPNN/HMM recognition system for online Arabic Handwritten script." In 2013 World Congress on Computer and Information Technology (WCCIT). IEEE, 2013. http://dx.doi.org/10.1109/wccit.2013.6618744.
Full textChekhmane, G., and R. Benali. "EEG signals analysis using SVM and MLPNN classifiers for epilepsy detection." In 2022 5th International Symposium on Informatics and its Applications (ISIA). IEEE, 2022. http://dx.doi.org/10.1109/isia55826.2022.9993577.
Full textRojatkar, D. V., K. D. Chinchkhede, and G. G. Sarate. "Handwritten Devnagari consonants recognition using MLPNN with five fold cross validation." In 2013 International Conference on Circuits, Power and Computing Technologies (ICCPCT). IEEE, 2013. http://dx.doi.org/10.1109/iccpct.2013.6528992.
Full textFerrah, Imene, Ahmed Khaled Chaou, and Madjid Teguar. "Discharges Pattern Recognition on Uniformly Polluted Glass Surface Using an MLPNN Classifier." In 2021 IEEE Electrical Insulation Conference (EIC). IEEE, 2021. http://dx.doi.org/10.1109/eic49891.2021.9612333.
Full text